Exploring Plant-Derived Medicinal Compounds: From Traditional Wisdom to Targeted Drug Discovery

A special issue of Plants (ISSN 2223-7747).

Deadline for manuscript submissions: 1 December 2024 | Viewed by 2262

Special Issue Editor


E-Mail Website
Guest Editor
Department of Pharmacology, School of Medicine, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa
Interests: phytopharmacology; medicinal plants; toxicology; drug development
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Plants have been a fundamental source of medicinal compounds for centuries, forming the basis of traditional healing practices across the globe. Throughout history, diverse cultures have harnessed the therapeutic potential of plants, passing down knowledge of herbal remedies from generation to generation. These traditional practices are rooted in empirical observations of the healing properties of specific plants. Ethnobotanical studies have played a crucial role in documenting this traditional wisdom, cataloging a wealth of plant-derived medicinal knowledge.

In recent decades, advances in science and technology have transformed our understanding of plant-derived compounds. The field of phytochemistry has enabled the isolation and characterization of bioactive molecules from medicinal plants, revealing their intricate chemical structures. Concurrently, modern pharmacology and molecular biology have shed light on the mechanisms of action of these compounds within the human body.

One of the most promising aspects of plant-derived medicinal compounds lies in their potential as a source of new drug candidates. Natural products from plants have served as inspiration for the development of pharmaceuticals targeting a wide range of diseases, including cancer, infectious diseases, and chronic conditions. Researchers are increasingly applying sophisticated techniques such as high-throughput screening and bioinformatics to identify and optimize plant-derived molecules for drug discovery.

The integration of traditional wisdom about medicinal plants with cutting-edge research methods holds immense potential for the development of novel drugs that are both effective and culturally relevant.

This Special Issue of Plants will highlight / This Special Issue aims to provide examples of plant-derived medicines sourced through traditional wisdom and their development to modern applications in targeted drug discovery and medicinal use.

In this Special Issue, original research articles and reviews are welcome. Research areas may include (but not limited to) the following:

Biological activity of medicinal plants, biological effects of active substances from plants; phytomedicine; new plant products, active substances and secondary metabolites; plant drug development

I/We look forward to receiving your contributions.

Prof. Dr. Vanessa Steenkamp
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Plants is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • traditional medicine
  • medicinal compounds
  • plants
  • targeted drug discovery

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

23 pages, 11937 KiB  
Review
The Medicinal Species of the Lycium Genus (Goji Berries) in East Asia: A Review of Its Effect on Cell Signal Transduction Pathways
by Chenyu Jiang, Ziyu Chen, Weilin Liao, Ren Zhang, Geer Chen, Lijuan Ma and Haijie Yu
Plants 2024, 13(11), 1531; https://doi.org/10.3390/plants13111531 - 31 May 2024
Cited by 2 | Viewed by 1613
Abstract
Natural plants contain numerous chemical compounds that are beneficial to human health. The berries from the Lycium genus are widely consumed and are highly nutritious. Moreover, their chemical constituents have attracted attention for their health-promoting properties. In East Asia, there are three varieties [...] Read more.
Natural plants contain numerous chemical compounds that are beneficial to human health. The berries from the Lycium genus are widely consumed and are highly nutritious. Moreover, their chemical constituents have attracted attention for their health-promoting properties. In East Asia, there are three varieties of the Lycium genus (Lycium barbarum L., Lycium chinense Miller, and L. ruthenicum Murray) that possess medicinal value and are commonly used for treating chronic diseases and improving metabolic disorders. These varieties are locally referred to as “red Goji berries” or “black Goji berries” due to their distinct colors, and they differ in their chemical compositions, primarily in terms of carotenoid and anthocyanin content. The pharmacological functions of these berries include anti-aging, antioxidant, anti-inflammatory, and anti-exercise fatigue effects. This review aims to analyze previous and recent studies on the active ingredients and pharmacological activities of these Lycium varieties, elucidating their signaling pathways and assessing their impact on the gut microbiota. Furthermore, the potential prospects for using these active ingredients in the treatment of COVID-19 are evaluated. This review explores the potential targets of these Lycium varieties in the treatment of relevant diseases, highlighting their potential value in drug development. Full article
Show Figures

Graphical abstract

Back to TopTop